Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: GRITSTONE BIO, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2023-09-25 to 2025-03-31
Current total value of award: $9856008
Description: DEVELOPING A NEXT-GENERATION VACCINE THAT DRIVES (A) MORE DURABLE AND BROAD ANTI-SPIKE NEUTRALIZING ANTIBODIES (NABS) AGAINST VARIANTS OF CONCERN (VOCS), INCLUDING THOSE NOT INCLUDED IN THE VACCINE, AND (B) T CELLS REACTIVE AGAINST CONSERVED TARGETS